• All
  • Article Title
  • Abstract
  • Keywords
  • Author
  • Institution
  • Special Issue Topic

    Evaluation and Outcomes in the Management of Gout

    Submission Deadline: October 31, 2025

    Guest Editor

    Prof. Fernando Pérez-Ruiz E-Mail

    Senior Consultant and Chief of the Rheumatology Division in Cruces University Hospital; Head of the Investigation Group for Arthritis at BIOBizkaia Health Research Institute; Associated Professor of the Department of Medicine in School of Medicine and Nursery at the Basque Country University, Biscay, Spain


    About the Special Issue

    Gout is overall a neglected disease. Most audits and studies evaluating the management of the disease show, even in the most developed countries, that diagnosis is not necessarily based on standards, the burden of disease is not considered, and pain killers, and not urate-lowering therapy, still account for the most common prescriptions.

    In this special issue EMD welcomes submissions regarding the evaluation such as evaluation of burden of disease, accommodation of prescriptions to recommendations and guidelines, evaluation of outcomes either laboratory (target serum urate levels), clinical (flares, patient reported outcomes/PROs), and imaging.

    Last, but not least, pharmacoeconomic studies and patient's reported expectations/PREs would also be included.

    Keywords: Gout, management, evaluation, audits, burden of disease

    Call for Papers

    Published Articles

    Open Access
    Review
    Management of gout in advanced renal disease
    Gout is the most common inflammatory arthritis, and its prevalence is increasing in part due to the rise in chronic kidney disease (CKD). Guidelines for managing gout from the American College of Rh [...] Read more.
    John S. Richards ... Mohan Ramkumar
    Published: May 07, 2025 Explor Musculoskeletal Dis. 2025;3:100791
    DOI: https://doi.org/10.37349/emd.2025.100791
    View:205
    Download:5
    Times Cited: 0